These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19698067)

  • 1. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.
    Molife C; Lee LJ; Shi L; Sawhney M; Lenox SM
    Diabetes Technol Ther; 2009 Aug; 11(8):529-38. PubMed ID: 19698067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
    Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
    Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.
    Baser O; Bouchard J; DeLuzio T; Henk H; Aagren M
    Adv Ther; 2010 Feb; 27(2):94-104. PubMed ID: 20352392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis.
    Lasalvia P; Barahona-Correa JE; Romero-Alvernia DM; Gil-Tamayo S; Castañeda-Cardona C; Bayona JG; Triana JJ; Laserna AF; Mejía-Torres M; Restrepo-Jimenez P; Jimenez-Zapata J; Rosselli D
    J Diabetes Sci Technol; 2016 Jul; 10(4):959-66. PubMed ID: 26920639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses.
    Campos C; Lajara R; Deluzio T
    Expert Opin Pharmacother; 2012 Sep; 13(13):1837-46. PubMed ID: 22873943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials.
    Asche CV; Luo W; Aagren M
    Curr Med Res Opin; 2013 Oct; 29(10):1287-96. PubMed ID: 23865725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh.
    Kamrul-Hasan ABM; Hannan MA; Alam MS; Rahman MM; Asaduzzaman M; Mustari M; Paul AK; Kabir ML; Chowdhury SR; Talukder SK; Sarkar S; Hannan MA; Islam MR; Iftekhar MH; Robel MAB; Selim S
    BMC Endocr Disord; 2023 Feb; 23(1):37. PubMed ID: 36782190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, prevalence, and trend analysis of the use of insulin delivery systems in the United States (2005 to 2011).
    Perez-Nieves M; Jiang D; Eby E
    Curr Med Res Opin; 2015 May; 31(5):891-9. PubMed ID: 25710707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.
    Graff MR; McClanahan MA
    Clin Ther; 1998; 20(3):486-96. PubMed ID: 9663364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.